TCL Archive DCE Board Approves Concept For New $850,000 Year Grant Program To Study Viruses In Cervical Cancer November 9, 1984
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive NCI, ACS Agree On Interim Mammography Guides Dropping Routine Use for Women Under Age 50 August 27, 1976